|
|
|
Volumn 26, Issue 5 SUPPL. 14, 1999, Pages 52-57
|
|
The role of CAMPATH-I antibodies in the treatment of lymphoid malignancies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
CD52 ANTIGEN;
ANTINEOPLASTIC AGENT;
CANCER ANTIBODY;
GLYCOPROTEIN;
LEUKOCYTE ANTIGEN;
MONOCLONAL ANTIBODY;
TUMOR ANTIGEN;
ARTICLE;
CANCER IMMUNOTHERAPY;
CHRONIC LYMPHATIC LEUKEMIA;
HUMAN;
PRIORITY JOURNAL;
PROLYMPHOCYTIC LEUKEMIA;
REMISSION;
TREATMENT OUTCOME;
IMMUNOLOGY;
LEUKEMIA;
LYMPHOMA;
REVIEW;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
ANTIGENS, CD;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
GLYCOPROTEINS;
HUMANS;
LEUKEMIA;
LYMPHOMA;
|
|
EID: 0032589668
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (83)
|
|
References (28)
|
